Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_1_2
1
100%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Phase 1/2Combined phases
1(100.0%)

Highest Phase Reached

Phase 1/2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

1

all time

Status Distribution
Active(1)

Detailed Status

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
0
Success Rate
N/A
Most Advanced
Phase 1/2

Trials by Phase

Phase 1/21 (100.0%)

Trials by Status

not_yet_recruiting1100%

Recent Activity

0 active trials
Showing 1 of 1
not_yet_recruitingphase_1_2

Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection)

NCT07282457

Clinical Trials (1)

Showing 1 of 1 trials
NCT07282457Phase 1/2

Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection)

Not Yet Recruiting

All 1 trials loaded

Drug Details

Intervention Type
Genetic
Total Trials
1